The new FDA rules for pregnancy and lactation labeling
DOI:
https://doi.org/10.25118/2236-918X-5-5-5Keywords:
Labeling, drug, pregnancy, lactationAbstract
New rules set forth by the Food and Drug Administration (FDA) for the use of drugs during pregnancy and lactation take effect this year (2015). They reshape the content and format of labeling and concomitantly remove any reference to the A, B, C, D, and X categories. The latter are replaced by a summary of the perinatal risks associated with the drug, discussion of related evidence, and a summary of the most relevant data for prescription decision-making. Also, the new rules include essential information on the identificati on of pregnancy, contraception, and infertility. The ultimate goal of the new rules is to facilitate the process of prescribing drugs by offering consistent, well-structuredinformation about the use of drugs during pregnancy and lactation.
Downloads
Metrics
References
Koren G, Gadot Y. Medicati on use in pregnancy; treati ng the mother: protecti ng the unborn. In: Harrison-Wollrich M. Medicines for women. New York: Springer; 2015.
Ramoz LL, Patel-Shori NM. Recent changes in pregnancy and lactati on labeling: reti rement of risk categories. Pharmacotherapy. 2014;34:389-95.
Källén B, Borg N, Reis M. The use of central nervous system acti ve drugs during pregnancy. Pharmaceuti cals (Basel). 2013;6:1221-86.
Pearlstein T. Use of psychotropic medicati on during pregnancy and the postpartum period. Womens Health (Lond Engl). 2013;9:605-15.
Ray S, Stowe ZN. The use of anti depressant medicati on in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2014;28:71-83.
Freeman MP. Pregnancy and psychiatric disorders: inherent risks and treatment decisions. J Clin Psychiatry. 2013;74:373-4.
Koren G, Madjunkova S, Maltepe C. Bias against the null hypothesis: scaring pregnant women about drugs in pregnancy. Can Fam Physician. 2014;60:441-2.
Namouz-Haddad S, Nulman I. Safety of treatment of obsessive compulsive disorder in pregnancy and puerperium. Can Fam Physician. 2014;60:133-6.
IV Diretrizes Brasileiras para o Manejo da Asma. J Bras Pneumol. 2006;32(Supl 7):S447-74.
Drug labeling and pregnancy. Lancet. 2014:384:2084.
Feibus KB. FDA’s proposed rule for pregnancy and lactati on labeling: improving maternal child health through well-informed medicine use. J Med Toxicol. 2008:4;284-8.
Cohen L. The MGH Center for Women’s Mental Health. FDA’s new labeling rule: clinical implicati on [Internet]. 2015 Jan 28 [cited 2015 Aug 12]. http://womensmentalhealth.org/posts/fdas-newlabeling-rule-clinical-implicati ons/
Canti lino A, Lorenzo L, Paula Jdos A, Einarson A. Use of psychotropic medicati ons during pregnancy: percepti on of teratogenic risk among physicians in two Lati n American countries. Rev Bras Psiquiatr. 2014;36:106-10.
Einarson A, Davis W. Barriers to the pharmacological treatment of women with psychiatric disorders during pregnancy and breastf eeding: results of a survey. J Obstet Gynaecol Can. 2013;35:504-5.
Rennó Junior J, Ribeiro HL. Tratado de saúde mental da mulher. São Paulo: Atheneu; 2012.
Food and Drug Administrati on, HHS. Content and format of labeling for human prescripti on drug and biological products; requirements for pregnancy and lactati on labeling. Final rule. Fed Regist. 2014;79:72063-103.
Downloads
Published
How to Cite
Conference Proceedings Volume
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
